Cargando…
Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients
BACKGROUND: The SARS-CoV-2 pandemic has overwhelmed hospital services due to the rapid transmission of the virus and its severity in a high percentage of cases. Having tools to predict which patients can be safely early discharged would help to improve this situation. METHODS: Patients confirmed as...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282584/ https://www.ncbi.nlm.nih.gov/pubmed/35834501 http://dx.doi.org/10.1371/journal.pone.0269875 |
_version_ | 1784747135272484864 |
---|---|
author | Trujillo-Rodriguez, María Muñoz-Muela, Esperanza Serna-Gallego, Ana Praena-Fernández, Juan Manuel Pérez-Gómez, Alberto Gasca-Capote, Carmen Vitallé, Joana Peraire, Joaquim Palacios-Baena, Zaira R. Cabrera, Jorge Julio Ruiz-Mateos, Ezequiel Poveda, Eva López-Cortés, Luis Eduardo Rull, Anna Gutierrez-Valencia, Alicia López-Cortés, Luis Fernando |
author_facet | Trujillo-Rodriguez, María Muñoz-Muela, Esperanza Serna-Gallego, Ana Praena-Fernández, Juan Manuel Pérez-Gómez, Alberto Gasca-Capote, Carmen Vitallé, Joana Peraire, Joaquim Palacios-Baena, Zaira R. Cabrera, Jorge Julio Ruiz-Mateos, Ezequiel Poveda, Eva López-Cortés, Luis Eduardo Rull, Anna Gutierrez-Valencia, Alicia López-Cortés, Luis Fernando |
author_sort | Trujillo-Rodriguez, María |
collection | PubMed |
description | BACKGROUND: The SARS-CoV-2 pandemic has overwhelmed hospital services due to the rapid transmission of the virus and its severity in a high percentage of cases. Having tools to predict which patients can be safely early discharged would help to improve this situation. METHODS: Patients confirmed as SARS-CoV-2 infection from four Spanish hospitals. Clinical, demographic, laboratory data and plasma samples were collected at admission. The patients were classified into mild and severe/critical groups according to 4-point ordinal categories based on oxygen therapy requirements. Logistic regression models were performed in mild patients with only clinical and routine laboratory parameters and adding plasma pro-inflammatory cytokine levels to predict both early discharge and worsening. RESULTS: 333 patients were included. At admission, 307 patients were classified as mild patients. Age, oxygen saturation, Lactate Dehydrogenase, D-dimers, neutrophil-lymphocyte ratio (NLR), and oral corticosteroids treatment were predictors of early discharge (area under curve (AUC), 0.786; sensitivity (SE) 68.5%; specificity (S), 74.5%; positive predictive value (PPV), 74.4%; and negative predictive value (NPV), 68.9%). When cytokines were included, lower interferon-γ-inducible protein 10 and higher Interleukin 1 beta levels were associated with early discharge (AUC, 0.819; SE, 91.7%; S, 56.6%; PPV, 69.3%; and NPV, 86.5%). The model to predict worsening included male sex, oxygen saturation, no corticosteroids treatment, C-reactive protein and Nod-like receptor as independent factors (AUC, 0.903; SE, 97.1%; S, 68.8%; PPV, 30.4%; and NPV, 99.4%). The model was slightly improved by including the determinations of interleukine-8, Macrophage inflammatory protein-1 beta and soluble IL-2Rα (CD25) (AUC, 0.952; SE, 97.1%; S, 98.1%; PPV, 82.7%; and NPV, 99.6%). CONCLUSIONS: Clinical and routine laboratory data at admission strongly predict non-worsening during the first two weeks; therefore, these variables could help identify those patients who do not need a long hospitalization and improve hospital overcrowding. Determination of pro-inflammatory cytokines moderately improves these predictive capacities. |
format | Online Article Text |
id | pubmed-9282584 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-92825842022-07-15 Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients Trujillo-Rodriguez, María Muñoz-Muela, Esperanza Serna-Gallego, Ana Praena-Fernández, Juan Manuel Pérez-Gómez, Alberto Gasca-Capote, Carmen Vitallé, Joana Peraire, Joaquim Palacios-Baena, Zaira R. Cabrera, Jorge Julio Ruiz-Mateos, Ezequiel Poveda, Eva López-Cortés, Luis Eduardo Rull, Anna Gutierrez-Valencia, Alicia López-Cortés, Luis Fernando PLoS One Research Article BACKGROUND: The SARS-CoV-2 pandemic has overwhelmed hospital services due to the rapid transmission of the virus and its severity in a high percentage of cases. Having tools to predict which patients can be safely early discharged would help to improve this situation. METHODS: Patients confirmed as SARS-CoV-2 infection from four Spanish hospitals. Clinical, demographic, laboratory data and plasma samples were collected at admission. The patients were classified into mild and severe/critical groups according to 4-point ordinal categories based on oxygen therapy requirements. Logistic regression models were performed in mild patients with only clinical and routine laboratory parameters and adding plasma pro-inflammatory cytokine levels to predict both early discharge and worsening. RESULTS: 333 patients were included. At admission, 307 patients were classified as mild patients. Age, oxygen saturation, Lactate Dehydrogenase, D-dimers, neutrophil-lymphocyte ratio (NLR), and oral corticosteroids treatment were predictors of early discharge (area under curve (AUC), 0.786; sensitivity (SE) 68.5%; specificity (S), 74.5%; positive predictive value (PPV), 74.4%; and negative predictive value (NPV), 68.9%). When cytokines were included, lower interferon-γ-inducible protein 10 and higher Interleukin 1 beta levels were associated with early discharge (AUC, 0.819; SE, 91.7%; S, 56.6%; PPV, 69.3%; and NPV, 86.5%). The model to predict worsening included male sex, oxygen saturation, no corticosteroids treatment, C-reactive protein and Nod-like receptor as independent factors (AUC, 0.903; SE, 97.1%; S, 68.8%; PPV, 30.4%; and NPV, 99.4%). The model was slightly improved by including the determinations of interleukine-8, Macrophage inflammatory protein-1 beta and soluble IL-2Rα (CD25) (AUC, 0.952; SE, 97.1%; S, 98.1%; PPV, 82.7%; and NPV, 99.6%). CONCLUSIONS: Clinical and routine laboratory data at admission strongly predict non-worsening during the first two weeks; therefore, these variables could help identify those patients who do not need a long hospitalization and improve hospital overcrowding. Determination of pro-inflammatory cytokines moderately improves these predictive capacities. Public Library of Science 2022-07-14 /pmc/articles/PMC9282584/ /pubmed/35834501 http://dx.doi.org/10.1371/journal.pone.0269875 Text en © 2022 Trujillo-Rodriguez et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Trujillo-Rodriguez, María Muñoz-Muela, Esperanza Serna-Gallego, Ana Praena-Fernández, Juan Manuel Pérez-Gómez, Alberto Gasca-Capote, Carmen Vitallé, Joana Peraire, Joaquim Palacios-Baena, Zaira R. Cabrera, Jorge Julio Ruiz-Mateos, Ezequiel Poveda, Eva López-Cortés, Luis Eduardo Rull, Anna Gutierrez-Valencia, Alicia López-Cortés, Luis Fernando Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients |
title | Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients |
title_full | Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients |
title_fullStr | Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients |
title_full_unstemmed | Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients |
title_short | Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients |
title_sort | clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized sars-cov-2 infected patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282584/ https://www.ncbi.nlm.nih.gov/pubmed/35834501 http://dx.doi.org/10.1371/journal.pone.0269875 |
work_keys_str_mv | AT trujillorodriguezmaria clinicallaboratorydataandinflammatorybiomarkersatbaselineasearlydischargepredictorsinhospitalizedsarscov2infectedpatients AT munozmuelaesperanza clinicallaboratorydataandinflammatorybiomarkersatbaselineasearlydischargepredictorsinhospitalizedsarscov2infectedpatients AT sernagallegoana clinicallaboratorydataandinflammatorybiomarkersatbaselineasearlydischargepredictorsinhospitalizedsarscov2infectedpatients AT praenafernandezjuanmanuel clinicallaboratorydataandinflammatorybiomarkersatbaselineasearlydischargepredictorsinhospitalizedsarscov2infectedpatients AT perezgomezalberto clinicallaboratorydataandinflammatorybiomarkersatbaselineasearlydischargepredictorsinhospitalizedsarscov2infectedpatients AT gascacapotecarmen clinicallaboratorydataandinflammatorybiomarkersatbaselineasearlydischargepredictorsinhospitalizedsarscov2infectedpatients AT vitallejoana clinicallaboratorydataandinflammatorybiomarkersatbaselineasearlydischargepredictorsinhospitalizedsarscov2infectedpatients AT perairejoaquim clinicallaboratorydataandinflammatorybiomarkersatbaselineasearlydischargepredictorsinhospitalizedsarscov2infectedpatients AT palaciosbaenazairar clinicallaboratorydataandinflammatorybiomarkersatbaselineasearlydischargepredictorsinhospitalizedsarscov2infectedpatients AT cabrerajorgejulio clinicallaboratorydataandinflammatorybiomarkersatbaselineasearlydischargepredictorsinhospitalizedsarscov2infectedpatients AT ruizmateosezequiel clinicallaboratorydataandinflammatorybiomarkersatbaselineasearlydischargepredictorsinhospitalizedsarscov2infectedpatients AT povedaeva clinicallaboratorydataandinflammatorybiomarkersatbaselineasearlydischargepredictorsinhospitalizedsarscov2infectedpatients AT lopezcortesluiseduardo clinicallaboratorydataandinflammatorybiomarkersatbaselineasearlydischargepredictorsinhospitalizedsarscov2infectedpatients AT rullanna clinicallaboratorydataandinflammatorybiomarkersatbaselineasearlydischargepredictorsinhospitalizedsarscov2infectedpatients AT gutierrezvalenciaalicia clinicallaboratorydataandinflammatorybiomarkersatbaselineasearlydischargepredictorsinhospitalizedsarscov2infectedpatients AT lopezcortesluisfernando clinicallaboratorydataandinflammatorybiomarkersatbaselineasearlydischargepredictorsinhospitalizedsarscov2infectedpatients |